Related Experiment Videos
Long-term anticoagulation with recombinant hirudin in a patient on left ventricular assist device support
R Tandler1, M Weyand, C Schmid
1Department of Cardio-Thoracic Surgery, Westfälische Wilhelms-Universität, Muenster, Germany.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|December 8, 2000
Abstract:
We report on a 24 year old man with a Novacor left ventricular assist device (LVAD) who underwent long-term treatment with intravenous recombinant hirudin due to a heparin induced thrombocytopenia (HIT II) after suffering from an ischemic stroke.